137 related articles for article (PubMed ID: 25114106)
1. 6-Methoxyflavone inhibits NFAT translocation into the nucleus and suppresses T cell activation.
So JS; Kim GC; Song M; Lee CG; Park E; Kim HJ; Kim YS; Jun CD; Im SH
J Immunol; 2014 Sep; 193(6):2772-83. PubMed ID: 25114106
[TBL] [Abstract][Full Text] [Related]
2. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
[TBL] [Abstract][Full Text] [Related]
3. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells.
Cron RQ; Bort SJ; Wang Y; Brunvand MW; Lewis DB
J Immunol; 1999 Jan; 162(2):860-70. PubMed ID: 9916709
[TBL] [Abstract][Full Text] [Related]
4. A distal cis-regulatory element, CNS-9, controls NFAT1 and IRF4-mediated IL-10 gene activation in T helper cells.
Lee CG; Kang KH; So JS; Kwon HK; Son JS; Song MK; Sahoo A; Yi HJ; Hwang KC; Matsuyama T; Yui K; Im SH
Mol Immunol; 2009 Feb; 46(4):613-21. PubMed ID: 18962896
[TBL] [Abstract][Full Text] [Related]
5. NFAT1 and JunB cooperatively regulate IL-31 gene expression in CD4+ T cells in health and disease.
Hwang JS; Kim GC; Park E; Kim JE; Chae CS; Hwang W; Lee C; Hwang SM; Wang HS; Jun CD; Rudra D; Im SH
J Immunol; 2015 Feb; 194(4):1963-74. PubMed ID: 25595785
[TBL] [Abstract][Full Text] [Related]
6. Evidence for suppressed activity of the transcription factor NFAT1 at its proximal binding element P0 in the IL-4 promoter associated with enhanced IL-4 gene transcription in T cells of atopic patients.
Wierenga EA; Walchner M; Kick G; Kapsenberg ML; Weiss EH; Messer G
Int Immunol; 1999 Feb; 11(2):297-306. PubMed ID: 10069428
[TBL] [Abstract][Full Text] [Related]
7. NFAT1 transcription factor in dendritic cells is required to modulate T helper cell differentiation.
Barboza BA; Fonseca BP; Viola JP
Immunobiology; 2014 Sep; 219(9):704-12. PubMed ID: 24894426
[TBL] [Abstract][Full Text] [Related]
8. Regulation of interferon-gamma gene expression by nuclear factor of activated T cells.
Kiani A; García-Cózar FJ; Habermann I; Laforsch S; Aebischer T; Ehninger G; Rao A
Blood; 2001 Sep; 98(5):1480-8. PubMed ID: 11520798
[TBL] [Abstract][Full Text] [Related]
9. NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Dietz L; Frommer F; Vogel AL; Vaeth M; Serfling E; Waisman A; Buttmann M; Berberich-Siebelt F
Eur J Immunol; 2015 May; 45(5):1377-89. PubMed ID: 25630465
[TBL] [Abstract][Full Text] [Related]
10. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production.
Koning H; Neijens HJ; Baert MR; Oranje AP; Savelkoul HF
Cytokine; 1997 Jun; 9(6):416-26. PubMed ID: 9199876
[TBL] [Abstract][Full Text] [Related]
11. Lysine 313 of T-box is crucial for modulation of protein stability, DNA binding, and threonine phosphorylation of T-bet.
Jang EJ; Park HR; Hong JH; Hwang ES
J Immunol; 2013 Jun; 190(11):5764-70. PubMed ID: 23616576
[TBL] [Abstract][Full Text] [Related]
12. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
13. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
14. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization.
Hattori K; Nishikawa M; Watcharanurak K; Ikoma A; Kabashima K; Toyota H; Takahashi Y; Takahashi R; Watanabe Y; Takakura Y
J Immunol; 2010 Mar; 184(5):2729-35. PubMed ID: 20107184
[TBL] [Abstract][Full Text] [Related]
15. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
16. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription.
Monticelli S; Rao A
Eur J Immunol; 2002 Oct; 32(10):2971-8. PubMed ID: 12355451
[TBL] [Abstract][Full Text] [Related]
17. PTD-mediated intracellular delivery of mutant NFAT minimum DNA binding domain inhibited the proliferation of T cells.
Liu X; Zhao Q; Peng X; Xia S; Shen W; Zong Y; Cheng J; Wu W; Zhang M; Du F; Xu W; Qian H; Shao Q
Int Immunopharmacol; 2014 Mar; 19(1):110-8. PubMed ID: 24440534
[TBL] [Abstract][Full Text] [Related]
18. Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-gamma promoter that is a potential NFAT binding site.
Campbell PM; Pimm J; Ramassar V; Halloran PF
Transplantation; 1996 Mar; 61(6):933-9. PubMed ID: 8623163
[TBL] [Abstract][Full Text] [Related]
19. TCR-stimulated naive human CD4+ 45RO- T cells develop into effector cells that secrete IL-13, IL-5, and IFN-gamma, but no IL-4, and help efficient IgE production by B cells.
Brinkmann V; Kristofic C
J Immunol; 1995 Apr; 154(7):3078-87. PubMed ID: 7897199
[TBL] [Abstract][Full Text] [Related]
20. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
